Heather Verry: Diabetes New Zealand CEO on the funding of wearable glucose monitors
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Heather Verry: Diabetes New Zealand CEO on the funding of wearable glucose monitors
-
Narrated by:
-
By:
About this listen
Thousands of cases of amputation and vision loss could be prevented thanks to diabetes monitoring technology.
Continuous Glucose Monitors, or CGMs, have been funded for Type 1 diabetes since last October.
New data from CGM producer Dexcom finds lifetime use of the devices could prevent up to 70 thousand diabetes-related complications and save the country $50 thousand a day.
Diabetes New Zealand Chief Executive Heather Verry told Mike Hosking funding should be expanded to all diabetes patients.
She says Pharmac is only funding for Type 1, and at $200 a month, these devices are unaffordable for everyone else.
LISTEN ABOVE
See omnystudio.com/listener for privacy information.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.